UMass Team Highlights Cannabis Industry Capital Allocation Issues
The cannabis industry capital allocation heavily favors product development over medical research. This imbalance creates a gap in clinical evidence that affects patient care. UMass researchers emphasize the need for better funding distribution to…
Hot Picks: Cannabis consolidation and global demand fuel sector outlook
The cannabis sector outlook 2026 highlights key trends in market consolidation and global demand shaping the industry. These developments influence medical cannabis product quality and research funding. Understanding this outlook is essential for…
Cannabis Rescheduling Testimony in Congress (Newsletter: April 7, 2026)
The cannabis rescheduling testimony in Congress is a pivotal moment for federal cannabis policy. This testimony influences clinical practice by addressing regulatory barriers and prescribing pathways. Healthcare providers should monitor these…
Iowa House Panel Advances Bill to Fund Pediatric Cancer Research | News From The States
The Iowa House panel advances pediatric oncology research funding, aiming to support childhood cancer studies. This funding could influence pediatric cancer and cannabis research policies. Details on cannabis-specific provisions remain unclear, requiring…
Avicanna’s 2025 Audited Financial Statements Reveal Industry Insights
Corporate financial reporting cannabis provides insights into industry stability and research funding. Avicanna's 2025 audited financial statements highlight these aspects. Understanding financial health helps gauge sustained product availability.
Bill Aims to Boost Pediatric Cancer Research Funding in Iowa
Increased pediatric oncology supportive care research funding could enhance understanding of cannabis applications in pediatric cancer treatment. Children with cancer face unique challenges that conventional therapies may not fully address. This funding…
